| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. | Chief Operations Officer | Common Stock | 653K | $741K | $1.14 | Apr 20, 2023 | Direct |
| Outlook Therapeutics, Inc. | Chief Operations Officer | Stock Option (Right to Buy) | 192K | Apr 17, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Apr 20, 2023 | 1 | -$590K | 4 | Apr 21, 2023 | Chief Operations Officer |
| OTLK | Outlook Therapeutics, Inc. | Apr 17, 2023 | 1 | $0 | 4 | Apr 19, 2023 | Chief Operations Officer |
| OTLK | Outlook Therapeutics, Inc. | Jun 21, 2022 | 1 | $10.5K | 4 | Jun 23, 2022 | Chief Operating Officer |
| OTLK | Outlook Therapeutics, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Chief Operating Officer |
| OTLK | Outlook Therapeutics, Inc. | Dec 21, 2021 | 1 | $0 | 4 | Dec 23, 2021 | Chief Operating Officer |
| OTLK | Outlook Therapeutics, Inc. | Dec 6, 2021 | 1 | $34.8K | 4 | Dec 6, 2021 | Chief Operating Officer |
| OTLK | Outlook Therapeutics, Inc. | Dec 3, 2021 | 1 | $14.2K | 4 | Dec 3, 2021 | Chief Operating Officer |